Freda C. Lewis-Hall, M.D., DFAPA, has been appointed as Chief Medical Officer and Executive Vice President, Pfizer Inc. Dr. Lewis-Hall will be the senior physician in the company, responsible for enterprise-wide medical, patient safety, regulatory affairs and quality assurance as well as outreach to doctors and other medical professionals. Dr. Lewis-Hall will report to Mr. Kindler and serve on Pfizer’s Executive Leadership Team, its most senior leadership group. She will shape Pfizer’s regulatory and medical policy during a time of fast-changing expectations for healthcare companies and a wave of new therapies in development, especially as information technologies change the ways companies develop medicines, clinicians prescribe them, and patients and payers value them. Prior to joining Pfizer, Dr. Lewis-Hall was Executive Vice President – Medicines Development of Vertex Pharmaceuticals where she was responsible for clinical and non-clinical development as well as both medical and regulatory; she also served as Senior Vice President of Medical Affairs at Bristol-Myers Squibb, Vice President of Research and Development at Pharmacia, and Product Team Leader at Eli Lilly and Company. Dr. Lewis-Hall is a Fellow of the American Academy of Psychiatry. She received her Bachelor of Arts and Sciences from The Johns Hopkins University and her Medical Doctorate from Howard University Hospital and College of Medicine.